+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Lewy Body Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Lewy Body Disease - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 80 Pages
  • Global
From
VRDN-001 Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

VRDN-001 Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
TEPEZZA Sales Forecast, and Market Size Analysis - 2034 - Product Thumbnail Image

TEPEZZA Sales Forecast, and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Hearing Loss - Pipeline Insight, 2026 - Product Thumbnail Image

Hearing Loss - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 80 Pages
  • Global
From
Lupus Nephritis - Pipeline Insight, 2026 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 180 Pages
  • Global
From
Von Willebrand's Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Von Willebrand's Disease - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Retinal Vein Occlusion - Pipeline Insight, 2026 - Product Thumbnail Image

Retinal Vein Occlusion - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Hemophilia B - Pipeline Insight, 2026 - Product Thumbnail Image

Hemophilia B - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 80 Pages
  • Global
From
Hyperphosphatemia - Pipeline Insight, 2026 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Hyperparathyroidism - Pipeline Insight, 2026 - Product Thumbnail Image

Hyperparathyroidism - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Hyperoxaluria - Pipeline Insight, 2026 - Product Thumbnail Image

Hyperoxaluria - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Hypersomnia - Pipeline Insight, 2026 - Product Thumbnail Image

Hypersomnia - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Down Syndrome - Pipeline Insight, 2026 - Product Thumbnail Image

Down Syndrome - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2026 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 80 Pages
  • Global
From
Hypertriglyceridemia - Pipeline Insight, 2026 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 80 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2026 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
Acute Kidney Injury - Pipeline Insight, 2026 - Product Thumbnail Image

Acute Kidney Injury - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 80 Pages
  • Global
From
Acute-on-Chronic Liver Failure (ACLF) - Pipeline Insight, 2026 - Product Thumbnail Image

Acute-on-Chronic Liver Failure (ACLF) - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Asthma - Pipeline Insight, 2026 - Product Thumbnail Image

Asthma - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2026 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more